To understand the mechanism underlying the benefit of fenofibrate on vascular complications in patients with type 2 diabetes, investigators assessed carotid intima thickness as a marker of subclinical atherosclerosis.
Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.
The method of individualized treatment effect prediction of fenofibrate on major cardiovascular events risk reduction in T2D can be used to guide clinical decision-making.
Multiple clinical studies have examined the efficacy of pitavastatin.
Risk of both ischemic stroke and coronary heart disease was elevated with high triglycerides and low high-density lipoprotein cholesterol.
The new guidelines call for treating low-density lipoprotein cholesterol in specific patient groups to lower goals than previously recommended.
Too few American young adults are receiving needed statin medications, according to findings published in JAMA Cardiology.
Fenofibrate therapy may reduce cardiovascular disease (CVD) in statin-treated patients with diabetes and dyslipidemia.
Women and minorities with HIV are less frequently tested for dyslipidemia, according to a new study from IDWeek 2016.
Even if the impact of a given medication on lipid profile is relatively minimal, and therefore unlikely to independently affect ASCVD risk, the cumulative effect is important and cannot be overlooked.
Blacks have increased incidence of hypertension, diabetes, and dyslipidemia but not atrial fibrillation.
Having both diseases raises a patient's chances for developing diabetes.
Serum 25-hydroxyvitamin D levels correlated with risk for dyslipidemia.
Adolescents with autism spectrum disorder appear to be more likely to develop the disease.
Follicle-stimulating hormone may interact with its receptors and lead to elevated LDL cholesterol in postmenopausal women.
Researchers noted an improvement in lipid profile for nutraceuticals alone or in combination in statin-intolerant patients.
Key features include elimination of treatment targets and additional testing only when rationale clear.
Findings in older men with high cholesterol and low testosterone.
Researchers have discovered that a common medication indicated for the treatment of high cholesterol may stimulate the same peroxisome proliferator-activated receptors (PPARs) as cannabinoids, which could lead to a new class of cannabis-like drugs to treat a range of conditions.
An increasingly sedentary lifestyle has been linked to coronary calcification, regardless of exercise or traditional risk factors.
Many patients with diabetes may not be adhering to medication regimens and are therefore experiencing higher rates of cardiac events.
About half of extremely obese children had elevated blood pressure or dyslipidemia.
Recommendations based on existing guidelines for general population; many gaps in knowledge.
About one in five had dyslipidemia; one in ten had high or borderline BP in 2011 to 2012.
Overweight or obese adults with risk cardiovascular disease risk factors should be referred for intensive behavioral counseling.
Endocrinology Advisor Articles
- Relationship Between HbA1c and Coronary Artery Disease
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cushing Syndrome Results in Poor Quality of Life Even After Remission
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- FDA to Review Gimoti for Diabetic Gastroparesis in Adult Women
- FDA Approves First Mobile App for Use in Preventing Pregnancy
- Hypothyroidism Predicts Atrial Tachyarrhythmia After AF Catheter Ablation
- Treating Painful Diabetic Peripheral Neuropathy With Electroacupuncture